Fingerprint
Dive into the research topics of 'An effective epigenetic-PARP inhibitor combination therapy for breast and ovarian cancers independent of BRCA mutations'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
An effective epigenetic-PARP inhibitor combination therapy for breast and ovarian cancers independent of BRCA mutations
Nicholas Pulliam, Fang Fang, Ali R. Ozes, Jessica Tang, Adeoluwa Adewuyi, Harold Keer, John Lyons, Stephen B. Baylin, Daniela Matei, Harikrishna Nakshatri, Feyruz V. Rassool, Kathy D. Miller, Kenneth P. Nephew
Research output: Contribution to journal › Article › peer-review
42
Scopus
citations